Cyberjaya, 29 April 2026 – DXN Holdings Bhd delivered a resilient full-year performance for FY2026, sustaining revenue at RM1.9 billion despite foreign exchange volatility and a more challenging global operating environment.

The nutraceutical products manufacturer said revenue for the financial year ended 28 February 2026 remained broadly in line with the previous year, supported by the continued strength of its global member network and steady demand across key markets. Excluding currency translation effects from the stronger Malaysian Ringgit, DXN recorded 12.1% underlying normalised revenue growth year-on-year.

Unlock the Full Article

This article is exclusive to The Ledger Asia Subsribers / PAID members.

Subscribe to Read More

Already have an account? Log in here

Author

Abigail Cheong
I am Abigail, a journalist at The Ledger Asia, covering business and finance with a focus on the Malaysian Stock Market and key economic developments across Asia. Known for clear, accessible reporting, I deliver insights that help readers understand market trends, corporate movements, and regional news shaping the Asian economy.